In addition, childhood cancer survivors who received higher doses of cranial radiation therapy to kill the cancer showed even greater risk of stroke in later life, according to the study, which appears in today’s issue of the Journal of Clinical Oncology and is available online.
“This is important because leukemia and brain tumors are the two most common types of childhood cancer, representing more than half of childhood cancers,” said Dr. Daniel Bowers, associate professor of pediatrics and lead author of the study.
Other studies have shown that survivors of childhood leukemia or brain cancer are also at higher risk for cardiac dysfunction, obesity, short stature, and hormone and neurocognitive deficits. This is the first study to examine the risk to survivors for late-occurring strokes, which occur at least five years after their cancer diagnosis.
Leukemia and brain tumors account for 53 percent of all cancers among children younger than 15 years of age and are annually diagnosed in more than 4,400 U.S. children. Most patients live at least five years beyond their diagnosis to become long-term cancer survivors — 79 percent for leukemia and 73 percent for brain tumors.
The peak incidence for both leukemia and brain tumors is during vulnerable neurocognitive development, so researchers suspect that the radiation therapy typically received at such a crucial time may influence the later risk for stroke.
Among the study’s findings:
- Compared with siblings, leukemia survivors were two to three times more likely to suffer a stroke.- Brain-cancer survivors were eight to 10 times more likely to suffer a stroke.
- Patients with a history of relapse of their cancer were at a greater risk for stroke, likely a result of increased radiation treatment, the researchers concluded.
The effects of late-occurring strokes, which can be life-threatening or result in permanent or severe disability, can be particularly devastating in these cases because they often hit when the childhood cancer survivors are reaching early adulthood – in their late 20s and early 30s.
“Many people think, ‘You’re five years out from your cancer, you must be cured, and you can get on with the rest of your life.’ But these patients suddenly develop a new complication of the cancer and its treatments,” Dr. Bowers said.
UT Southwestern is one of 26 sites participating in the Childhood Cancer Survivors Study on long-term side effects for cancer survivors. Children’s Medical Center Dallas is also a member and contributed patients to the study. The study established a database of information on some 14,000 patients who survived at least five years after being diagnosed with cancer during childhood. The national database includes about 4,000 leukemia survivors and about 1,700 survivors of brain tumors.
Dr. Bowers has been culling through the data involving strokes, and previously discovered a greater stroke risk for survivors of Hodgkin disease.
Brain tumors and leukemia might seem like apples and oranges because leukemia is a bone-marrow cancer and brain cancers are by definition tumors in the brain.
“But they are similar in important ways,” Dr. Bowers noted. “They both are most likely to occur in young childhood, and both groups also get targeted radiation therapy to the brain.”
The current treatment regiments for brain tumors and leukemia are aimed at reducing the use of radiation therapy, a move designed to lessen learning problems associated with radiation therapy.
“It would be interesting to see whether it may also impact the occurrence of strokes,” Dr. Bowers said.
Researchers are now formulating a follow-up study to identify a way of screening patients who might be at risk of having strokes, with the goal of eventually developing a preventive strategy.
Other researchers involved in the study were senior author Dr. Kevin Oeffinger, a former faculty member at UT Southwestern, now with Memorial Sloan-Kettering Cancer Center, as well as researchers from UT M.D. Anderson Cancer Center, the Food and Drug Administration, the Fred Hutchinson Cancer Research Center, the University of Michigan, St. Jude Children’s Research Hospital, and the Children’s National Medical Center.
Russell Rian | EurekAlert!
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences